Search research articles
Contact Us
Filters
Showing results (281-290 of 520) with videos related to
Page
of 52
Sort By:
World Journal of Nuclear Medicine
|
May 4, 2026
Multiple Unusual Distant Metastasis in TENIS: Comparative Evaluation of [ <sup>18</sup> F]FDG and [ <sup>68</sup> Ga]-FAPI-04 PET-CT Uptake Patterns at Metastatic Sites
Madhava Reddy Mali, Priyanka Verma, Sandip Basu
Journal of Nuclear Medicine Technology
|
June 9, 2026
Interlesional Heterogeneity Between [<sup>68</sup>Ga]Ga-DOTATATE and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT After [<sup>177</sup>Lu]Lu-DOTATATE PRRT in Well-Differentiated NET with Progressive Disease
Rahul Vithalrao Parghane, Roopal Agrawal, Sandip Basu
Journal of Nuclear Medicine Technology
|
June 9, 2026
De Novo Small Cell Neuroendocrine Carcinoma of the Prostate: Molecular Heterogeneity on Triple-Tracer PET/CT and Its Implications for Personalized Treatment Strategy
Rangat Bagasariya, Rahul Vithalrao Parghane, Sandip Basu
World Journal of Nuclear Medicine
|
May 2, 2019
Prevalence of hitherto unknown brain meningioma detected on <sup>68</sup>Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
Rahul V Parghane, Sanjay Talole, Sandip Basu
Journal of Nuclear Medicine Technology
|
June 21, 2014
18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement
Yogesh Shejul, Prashant N Chhajed, Sandip Basu
Clinical Nuclear Medicine
|
June 16, 2026
Targeted Alpha Therapy With [225Ac]Ac-DOTATATE Versus Salvage Retreatment PRRT With [177Lu]Lu-DOTATATE in Progressive Metastatic Neuroendocrine Tumor Patients After Initial Course of [177Lu]Lu-DOTATATE Treatment: An Observational Study Comparing the Therapeutic Response, Survival, and Clinical Toxicity
Roopal Agrawal, Rahul V Parghane, Sandip Basu
European Journal of Nuclear Medicine and Molecular Imaging
|
March 22, 2025
Intriguing combination of hepatic metastatic GIST and neuroendocrine tumor in the same patient: Disease monitoring and treatment guidance through dual tracer PET/CT and biopsy
Austin Saju, Rahul V Parghane, Sandip Basu
PET Clinics
|
May 10, 2016
Preface Radiation Therapy Planning with PET
Sushil Beriwal, Roger M Macklis, Sandip Basu
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2016
The Ongoing Misperception That Labeled Leukocyte Imaging Is Superior to 18F-FDG PET for Diagnosing Prosthetic Joint Infection
Thomas C Kwee, Sandip Basu, Abass Alavi
Clinical Nuclear Medicine
|
January 29, 2025
Tumor Lesion Uptake of [ 177 Lu]Lu-DOTA-Rituximab in Skeletal and Splenic Disease in Diffuse Large B-Cell Lymphoma
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Page
of 52
Search research articles
Search
Showing results (281-290 of 520) with videos related to
Sort By:
Page
of 52
World Journal of Nuclear Medicine
|
May 4, 2026
Multiple Unusual Distant Metastasis in TENIS: Comparative Evaluation of [ <sup>18</sup> F]FDG and [ <sup>68</sup> Ga]-FAPI-04 PET-CT Uptake Patterns at Metastatic Sites
Madhava Reddy Mali, Priyanka Verma, Sandip Basu
Journal of Nuclear Medicine Technology
|
June 9, 2026
Interlesional Heterogeneity Between [<sup>68</sup>Ga]Ga-DOTATATE and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT After [<sup>177</sup>Lu]Lu-DOTATATE PRRT in Well-Differentiated NET with Progressive Disease
Rahul Vithalrao Parghane, Roopal Agrawal, Sandip Basu
Journal of Nuclear Medicine Technology
|
June 9, 2026
De Novo Small Cell Neuroendocrine Carcinoma of the Prostate: Molecular Heterogeneity on Triple-Tracer PET/CT and Its Implications for Personalized Treatment Strategy
Rangat Bagasariya, Rahul Vithalrao Parghane, Sandip Basu
World Journal of Nuclear Medicine
|
May 2, 2019
Prevalence of hitherto unknown brain meningioma detected on <sup>68</sup>Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
Rahul V Parghane, Sanjay Talole, Sandip Basu
Journal of Nuclear Medicine Technology
|
June 21, 2014
18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement
Yogesh Shejul, Prashant N Chhajed, Sandip Basu
Clinical Nuclear Medicine
|
June 16, 2026
Targeted Alpha Therapy With [225Ac]Ac-DOTATATE Versus Salvage Retreatment PRRT With [177Lu]Lu-DOTATATE in Progressive Metastatic Neuroendocrine Tumor Patients After Initial Course of [177Lu]Lu-DOTATATE Treatment: An Observational Study Comparing the Therapeutic Response, Survival, and Clinical Toxicity
Roopal Agrawal, Rahul V Parghane, Sandip Basu
European Journal of Nuclear Medicine and Molecular Imaging
|
March 22, 2025
Intriguing combination of hepatic metastatic GIST and neuroendocrine tumor in the same patient: Disease monitoring and treatment guidance through dual tracer PET/CT and biopsy
Austin Saju, Rahul V Parghane, Sandip Basu
PET Clinics
|
May 10, 2016
Preface Radiation Therapy Planning with PET
Sushil Beriwal, Roger M Macklis, Sandip Basu
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2016
The Ongoing Misperception That Labeled Leukocyte Imaging Is Superior to 18F-FDG PET for Diagnosing Prosthetic Joint Infection
Thomas C Kwee, Sandip Basu, Abass Alavi
Clinical Nuclear Medicine
|
January 29, 2025
Tumor Lesion Uptake of [ 177 Lu]Lu-DOTA-Rituximab in Skeletal and Splenic Disease in Diffuse Large B-Cell Lymphoma
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Page
of 52